/West%20Pharmaceutical%20Services%2C%20Inc_%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Valued at $16 billion by market cap, West Pharmaceutical Services, Inc. (WST) is a leading global manufacturer of packaging and delivery systems for injectable drugs. Headquartered in Exton, Pennsylvania, the company serves pharmaceutical and biotech clients worldwide with products like rubber stoppers, seals, and auto-injectors.
The company is ready to announce its fiscal second-quarter earnings for 2025 before the market opens on Thursday, Jul. 24. Ahead of the event, analysts expect WST to report a profit of $1.51 per share on a diluted basis, down marginally from $1.52 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion.